CIRM

Research!America extends our congratulations again to all of our 2013 Advocacy Award winners. The dinner was a wonderful opportunity to thank our supporters and advocates for all of their hard work and recognize leaders in the research and advocacy communities. This year’€™s Advocacy Award winners were Sen. Richard Burr (R-NC); Sen. Bob Casey (D-PA); John F. Crowley, patient advocate and chairman and CEO of Amicus Therapeutics, Inc.; Mark Rosenberg, MD, president and CEO of The Task Force for Global Health; John Mendelsohn, MD, director of the Khalifa Institute for Personalized Cancer Therapy and former president at The University of Texas MD Anderson Cancer Center; Diane Rehm, host of ’€œ...
Dear Research Advocate, Today, the Senate is planning to vote on a bipartisan continuing resolution from Sens. Mikulski and Shelby to fund the federal government through the end of the year. The good news is that the bill includes an increase, albeit small ($71 million) in NIH funding; Senator Harkin tried, unsuccessfully, unfortunately, to increase NIH even further, and Senator Durbin worked on an ambitious amendment to add more than $1.5 billion to the NIH budget. We truly appreciate the efforts of all of these champions and the fact that NIH funding was singled out for an increase on a bipartisan basis by the Appropriations Committee. The bad news is that sequestration will wipe out all...
Research!America will honor extraordinary leaders in biomedical and health research advocacy at the 17th Annual Advocacy Awards tonight, March 13, at the Andrew W. Mellon Auditorium in Washington, DC. This year’€™s Advocacy Award Winners are: Sens. Richard Burr (R-NC) and Bob Casey (D-PA); Diane Rehm, author and host of WAMU 88.5 and NPR’€™s ’€œThe Diane Rehm Show’€; John F. Crowley, patient advocate, inspirational entrepreneur, and chairman and CEO of Amicus Therapeutics, Inc.; John Mendelsohn, MD, director, Khalifa Institute for Personalized Cancer Therapy and former president of The University of Texas MD Anderson Cancer Center; Mark Rosenberg, MD, president and CEO, The Task Force for...